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Although the prognosis of biliary carcinoma remains 
poor, no clinical practice guidelines for biliary tract and 
ampullary carcinomas have been published to date. We 
hope that the publication of Evidence-Based clinical 
practical guidelines for the management of biliary tract 
and ampullary carcinomas will contribute to the devel-
opment of evidence-based diagnosis and treatment in 
this ﬁ  eld.
I will describe how the present guidelines came to be 
published. In 2003, the publication of guidelines was 
proposed to the Japanese Association of Biliary Surgery 
as part of an Integrated Research Project for Assessing 
Medical Technology, sponsored by the Japanese 
Ministry of Health, Labour, and Welfare. Immediately, 
a working group was organized for the purpose of pre-
paring evidence-based guidelines. In 2005, the Japanese 
Association of Biliary Surgery and the Japanese Society 
of Hepato-Biliary-Pancreatic Surgery (JSHBPS) united, 
and the preparation of the guidelines was continued by 
the JSHBPS as its main task.
The guidelines were disclosed at the draft stage to 
facilitate external assessment, and the text: Evidence-
Based clinical practice guidelines for the management of 
biliary tract and ampullary carcinomas was later pub-
lished in collaboration with the Japan Society of Clinical 
Oncology and the Integrated Research Project 
for Assessing Medical Technology, sponsored by the 
Japanese Ministry of Health, Labour, and Welfare.
We believe these guidelines will be of great use and 
so we decided to publish an English-language version. 
It is anticipated that, in future, the volume of important 
evidence and evidence-based evaluations will increase 
the scope of the guidelines. To allow for the incorpora-
tion of evidence as it arises, the guidelines consist of 
independent articles on important subjects. An abstract 
of each article is followed by clinical questions to ensure 
that the guidelines may be used in everyday medical 
practice.
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